» Articles » PMID: 21258604

New Dendrimers: Synthesis and Characterization of Popam - Pamam Hybrid Dendrimers

Overview
Journal Macromolecules
Date 2011 Jan 25
PMID 21258604
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Recently developed multifunctional cancer therapeutic nano-device production is based on poly(amidoamine) PAMAM generation 5 (G5) dendrimer as a carrier 1-5. Scale up synthesis of this nano-device is limited because of long reaction sequence (12 reaction steps) and long and not easy work up of the products after each reaction step. Combination of poly(propyle-imine) and poly(amidoamine) synthesis can improve the production of the drug carrier.In this paper we give a general overview of the synthesis and characterization of a series of novel hybrid dendrimers which we coined as novel POMAM hybrid dendrimers, constructed from poly(propylene-imine) (PPI or POPAM) core and poly(amidoamine) PAMAM shells. The synthesis was accomplished by a divergent reiterating method involving repeating subsequent Michael addition and amidation reactions. Each generation of the newly synthesized dendrimer was characterized by using HPLC, GPC, NMR and AFM.

Citing Articles

Neutrophil-mediated and low density lipoprotein receptor-mediated dual-targeting nanoformulation enhances brain accumulation of scutellarin and exerts neuroprotective effects against ischemic stroke.

Dang Y, An C, Li Y, Han D, Liu X, Zhang F RSC Adv. 2022; 9(3):1299-1318.

PMID: 35518053 PMC: 9059646. DOI: 10.1039/c8ra06688d.


Recent Advances and Challenges in Nanodelivery Systems for Antimicrobial Peptides (AMPs).

Tang Z, Ma Q, Chen X, Chen T, Ying Y, Xi X Antibiotics (Basel). 2021; 10(8).

PMID: 34439040 PMC: 8388958. DOI: 10.3390/antibiotics10080990.


Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review.

Hossen S, Hossain M, Basher M, Mia M, Rahman M, Uddin M J Adv Res. 2018; 15:1-18.

PMID: 30581608 PMC: 6300464. DOI: 10.1016/j.jare.2018.06.005.


[Gene therapy and stem cells for the inner ear: a review].

Breinbauer H, Praetorius M HNO. 2014; 62(2):93-9.

PMID: 24549508 DOI: 10.1007/s00106-013-2822-0.


Dendrimers terminated with dichlorotriazine groups provide a route to compositional diversity.

Patra S, Kozura B, Huang A, Enciso A, Sun X, Hsieh J Org Lett. 2013; 15(15):3808-11.

PMID: 23869522 PMC: 4091816. DOI: 10.1021/ol400811h.


References
1.
Majoros I, Thomas T, Mehta C, Baker Jr J . Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J Med Chem. 2005; 48(19):5892-9. DOI: 10.1021/jm0401863. View

2.
van Hest J, Delnoye D, Baars M, van Genderen M, Meijer E . Polystyrene-dendrimer amphiphilic block copolymers with a generation-dependent aggregation. Science. 1995; 268(5217):1592-5. DOI: 10.1126/science.268.5217.1592. View

3.
Kukowska-Latallo J, Candido K, Cao Z, Nigavekar S, Majoros I, Thomas T . Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005; 65(12):5317-24. DOI: 10.1158/0008-5472.CAN-04-3921. View

4.
Thomas T, Majoros I, Kotlyar A, Kukowska-Latallo J, Bielinska A, Myc A . Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J Med Chem. 2005; 48(11):3729-35. DOI: 10.1021/jm040187v. View

5.
Majoros I, Myc A, Thomas T, Mehta C, Baker Jr J . PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules. 2006; 7(2):572-9. DOI: 10.1021/bm0506142. View